LISTI', Angela
 Distribuzione geografica
Continente #
NA - Nord America 4.145
EU - Europa 1.380
AS - Asia 1.253
Continente sconosciuto - Info sul continente non disponibili 244
SA - Sud America 238
AF - Africa 31
OC - Oceania 4
Totale 7.295
Nazione #
US - Stati Uniti d'America 4.077
SG - Singapore 434
IT - Italia 417
CN - Cina 354
RU - Federazione Russa 352
BR - Brasile 189
DE - Germania 144
VN - Vietnam 134
HK - Hong Kong 102
GB - Regno Unito 95
FI - Finlandia 71
PL - Polonia 65
FR - Francia 62
IE - Irlanda 52
CA - Canada 45
JP - Giappone 44
IN - India 34
KR - Corea 34
SE - Svezia 22
TR - Turchia 22
BD - Bangladesh 19
BE - Belgio 19
NL - Olanda 15
AR - Argentina 14
ES - Italia 14
IQ - Iraq 12
VE - Venezuela 11
UA - Ucraina 10
EC - Ecuador 9
MX - Messico 9
RO - Romania 9
AT - Austria 8
IR - Iran 8
ID - Indonesia 7
PY - Paraguay 7
ZA - Sudafrica 7
MA - Marocco 6
MY - Malesia 6
PK - Pakistan 6
UZ - Uzbekistan 5
CH - Svizzera 4
CI - Costa d'Avorio 4
CL - Cile 4
DK - Danimarca 4
SA - Arabia Saudita 4
BG - Bulgaria 3
CO - Colombia 3
DZ - Algeria 3
KE - Kenya 3
NI - Nicaragua 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
MO - Macao, regione amministrativa speciale della Cina 2
NP - Nepal 2
TH - Thailandia 2
TN - Tunisia 2
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
BW - Botswana 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
FJ - Figi 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KY - Cayman, isole 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LY - Libia 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UY - Uruguay 1
Totale 7.052
Città #
Fairfield 519
Ashburn 450
Singapore 271
San Jose 265
Seattle 243
Chandler 234
Woodbridge 219
Cambridge 183
Wilmington 182
Houston 172
Ann Arbor 127
Hong Kong 99
Palermo 95
Council Bluffs 83
Moscow 77
New York 63
Beijing 57
Boardman 52
Dublin 51
Zgierz 51
Los Angeles 50
Nanjing 50
Chicago 49
Medford 48
The Dalles 48
Ho Chi Minh City 41
Santa Clara 38
Tokyo 38
Des Moines 33
Helsinki 32
Lauterbourg 32
Princeton 31
Hanoi 29
Altamura 28
Lawrence 25
Dearborn 23
Panama City 23
Seoul 23
San Diego 22
Dallas 21
Hefei 21
Ludwigshafen am Rhein 21
Kitzingen 19
Brussels 18
Phoenix 18
London 17
Milan 17
Rome 17
Shenyang 17
Frankfurt am Main 16
Jinan 16
Warsaw 14
Buffalo 13
Da Nang 11
Falls Church 11
Redwood City 11
Montreal 10
Munich 10
Orem 10
Tianjin 10
Baghdad 9
Bremen 9
Brooklyn 9
Hebei 9
Kumar 9
São Paulo 9
Toronto 9
Amsterdam 8
Denver 8
Izmir 8
Rio de Janeiro 8
Stockholm 8
Tulsa 8
Atlanta 7
Belo Horizonte 7
Boydton 7
Changsha 7
Chennai 7
Columbus 7
Haiphong 7
Orange 7
Springfield 7
Tehran 7
Ankara 6
Düsseldorf 6
Ningbo 6
Norwalk 6
Poplar 6
San Paolo di Civitate 6
Boston 5
Guangzhou 5
Jiaxing 5
Marano di Napoli 5
Nanchang 5
Nuremberg 5
Washington 5
Abidjan 4
Buenos Aires 4
Cagliari 4
Casablanca 4
Totale 4.742
Nome #
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 371
EGFR inhibition in NSCLC: New findings…. and opened questions? 360
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 359
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 341
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 331
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 324
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 295
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 287
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 284
Nintedanib in NSCLC: Evidence to date and place in therapy 266
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 255
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 255
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer 243
Non-coding RNAs functioning in colorectal cancer stem cells 224
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 221
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 219
Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab 212
Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment 202
The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer 188
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 188
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 184
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab 179
Liquid Biopsy in Gynecological Cancers 179
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 177
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? 176
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 176
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma 171
UNRAVELLING THE ROLES OF THE NUCLEAR PROTEIN 1 DURING ER-STRESS INDUCTION 168
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 163
Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib 155
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 117
null 25
Totale 7.295
Categoria #
all - tutte 23.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.181


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022277 0 0 0 17 15 23 26 20 45 32 28 71
2022/2023615 50 115 9 89 64 86 28 63 64 6 28 13
2023/2024243 8 35 17 19 12 58 29 14 0 7 4 40
2024/2025640 7 31 13 54 34 39 64 55 33 94 90 126
2025/20262.270 166 85 124 212 245 316 332 285 168 147 83 107
2026/2027517 145 69 225 78 0 0 0 0 0 0 0 0
Totale 7.295